258 related articles for article (PubMed ID: 18794557)
1. Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease.
Lee TA; Pickard AS; Au DH; Bartle B; Weiss KB
Ann Intern Med; 2008 Sep; 149(6):380-90. PubMed ID: 18794557
[TBL] [Abstract][Full Text] [Related]
2. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
Lee TA; Schumock GT; Bartle B; Pickard AS
Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
[TBL] [Abstract][Full Text] [Related]
3. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
[TBL] [Abstract][Full Text] [Related]
4. Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.
Gershon AS; Campitelli MA; Croxford R; Stanbrook MB; To T; Upshur R; Stephenson AL; Stukel TA
JAMA; 2014 Sep; 312(11):1114-21. PubMed ID: 25226477
[TBL] [Abstract][Full Text] [Related]
5. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
[TBL] [Abstract][Full Text] [Related]
6. Drug use and pulmonary death rates in increasingly symptomatic asthma patients in the UK.
Meier CR; Jick H
Thorax; 1997 Jul; 52(7):612-7. PubMed ID: 9246132
[TBL] [Abstract][Full Text] [Related]
7. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
[TBL] [Abstract][Full Text] [Related]
8. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma.
Guite HF; Dundas R; Burney PG
Thorax; 1999 Apr; 54(4):301-7. PubMed ID: 10092690
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.
Gershon A; Croxford R; Calzavara A; To T; Stanbrook MB; Upshur R; Stukel TA
JAMA Intern Med; 2013 Jul; 173(13):1175-85. PubMed ID: 23689820
[TBL] [Abstract][Full Text] [Related]
12. Inhaled corticosteroids and mortality in COPD.
Macie C; Wooldrage K; Manfreda J; Anthonisen NR
Chest; 2006 Sep; 130(3):640-6. PubMed ID: 16963657
[TBL] [Abstract][Full Text] [Related]
13. Is there any association between inhaled ipratropium and mortality in patients with COPD and asthma?
Ringbaek T; Viskum K
Respir Med; 2003 Mar; 97(3):264-72. PubMed ID: 12645834
[TBL] [Abstract][Full Text] [Related]
14. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
Ohar JA; Donohue JF
Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
[TBL] [Abstract][Full Text] [Related]
15. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.
Gershon A; Croxford R; To T; Stanbrook MB; Upshur R; Sanchez-Romeu P; Stukel T
Ann Intern Med; 2011 May; 154(9):583-92. PubMed ID: 21536937
[TBL] [Abstract][Full Text] [Related]
16. Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials.
Dong YH; Lin HH; Shau WY; Wu YC; Chang CH; Lai MS
Thorax; 2013 Jan; 68(1):48-56. PubMed ID: 23042705
[TBL] [Abstract][Full Text] [Related]
17. Risk of stroke associated with inhaled ipratropium bromide in chronic obstructive pulmonary disease: a population-based nested case-control study.
Wang MT; Tsai CL; Lo YW; Liou JT; Lee WJ; Lai IC
Int J Cardiol; 2012 Jul; 158(2):279-84. PubMed ID: 22386700
[TBL] [Abstract][Full Text] [Related]
18. Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline.
Wilt TJ; Niewoehner D; MacDonald R; Kane RL
Ann Intern Med; 2007 Nov; 147(9):639-53. PubMed ID: 17975187
[TBL] [Abstract][Full Text] [Related]
19. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD.
Yamauchi Y; Yasunaga H; Hasegawa W; Sakamoto Y; Takeshima H; Jo T; Matsui H; Fushimi K; Nagase T
Int J Chron Obstruct Pulmon Dis; 2016; 11():1403-11. PubMed ID: 27382276
[TBL] [Abstract][Full Text] [Related]
20. Tiotropium Handihaler and the risk of cardio- or cerebrovascular events and mortality in patients with COPD.
Verhamme KM; Afonso AS; van Noord C; Haag MD; Koudstaal PJ; Brusselle GG; Sturkenboom MC
Pulm Pharmacol Ther; 2012 Feb; 25(1):19-26. PubMed ID: 22051450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
